1-3 of 3
Ashlin Yahr
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Effectively Targeting Burkitt Lymphoma By Anti-CD20 Chimeric Antigen Receptor (CAR) Modified Expanded Natural Killer Cells Combined with a Histone Deacetylase Inhibitor, Romidepsin in-Vitro and in Humanized NSG Mice

Yaya Chu, PhD, Ashlin Yahr, Janet Ayello, MS, MT(ASCP), Mitchell S. Cairo, MD
Journal: Blood
Blood (2014) 124 (21): 1108.
https://doi.org/10.1182/blood.V124.21.1108.1108
Published: 2014
Journal Articles

Anti-CD20 Chimeric Antigen Receptor (CAR) Modified Expanded Natural Killer (NK) Cells Significantly Mediate Burkitt Lymphoma (BL) Regression and Improve Survival In Human BL Xenografted NSG Mice

Yaya Chu, PhD, Ashlin Yahr, Janet Ayello, MS, MT(ASCP), Carmella van de Ven, MA, Xianzheng Zhou, MD, PhD, Mitchell S. Cairo, MD
Journal: Blood
Blood (2013) 122 (21): 3263.
https://doi.org/10.1182/blood.V122.21.3263.3263
Published: 2013
Journal Articles

Expanded Natural Killer (NK) Cells Transfected with Anti-CD20 Chimeric Antigen Receptor (CAR) mRNA Have Significant Cytotoxicity Against Poor Risk B-Cell (CD20 + ) Leukemia/Lymphoma (B-L/L).

Yaya Chu, PhD, Janet Ayello, MS, MT(ASCP), Lowrence Lo, Jared Katz, Ashlin Yahr, Jessica Hochberg, MD, Carmella van de Ven, MA, Xianzheng Zhou, MD, PhD, Mitchell S. Cairo, MD
Journal: Blood
Blood (2012) 120 (21): 3007.
https://doi.org/10.1182/blood.V120.21.3007.3007
Published: 2012